Meyers Steve Lawrence bought OCUL
January 2, 2026 · Form 4 insider transaction
Meyers Steve Lawrence bought 197,650 shares of Ocular Therapeutix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
197,650
Price
$0.00
Total value
N/A
InsiderMeyers Steve Lawrence
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after197,650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.